Search

everythinglearnresearchcommunity

for

Search:↓

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

New methods may speed up drug development for male subfertility.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Scientists can control how skin stem cells divide by using different treatments.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

More research is needed to find effective treatments for sickle cell disease-related priapism.

SSRI antidepressants can cause long-lasting sexual problems.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Treatments for urinary symptoms often cause ejaculatory problems.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New understanding and treatments for hair loss are improving, but more research is needed.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Finasteride can treat prostatic haematuria, but its use is controversial.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.